LDS/Medical Tests/1p/19q Deletion in Gliomas, FISH, Tissue

1p/19q Deletion in Gliomas, FISH, Tissue

The major histologic types of human gliomas are oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas and histologic differentiation among these tumors is sometimes challenging. It has been demonstrated that specific morphologic types of gliomas are highly associated with specific genetic alterations. There are some specific genetic alterations which seem to predict prognosis and response to specific chemotherapeutic and radiotherapeutic treatments, irrespective of tumor morphology. 19q, 1p, and both 19q and 1p deletions have been found in approximately 70%, 50%, and 50% of oligodendrogliomas, respectively. The occurrence of gliomas of oligodendroglial lineage are strongly correlated with deletions of the short arm of chromosome 1 and long arm of chromosome 19 and presence of combined 1p/19q loss is strongly suggestive that a glioma is an oligodendroglioma. Deletions of 1p or 1p and 19q together also have been connected with response to various radiotherapeutic and chemotherapeutic treatments. These reactions have been especially linked with high-grade oligodendrogliomas. In pediatric and adolescent oligodendroglial neoplasms, the occurrence of 1p/19q deletion is rare and therefore this test is not relevant.

In pure astrocytomas 1p/19q deletions are quite rare and this test is not generally recommended. Conversely, gliomas of astrocytic origin may demonstrate gains of chromosome 19 or 19q.

  • As an aid in diagnosis and predicting the therapeutic response of oligodendroglioma tumors
  • Differential diagnosis of mixed oligoastrocytomas from pure astrocytomas (in mixed oligoastrocytomas)
  • The detection of 1p deletion or both 1p and 19q deletion supports a diagnosis of oligodendroglioma and may indicate that the patient may respond to chemotherapy and radiation therapy
  • The detection of gains in chromosome 19 gain supports a diagnosis of high-grade astrocytoma (glioblastoma multiforme)
  • A negative result does not rule out a diagnosis of oligodendroglioma or high-grade astrocytoma

The result is within normal limits. No deletions of 1p and 19q were observed

Fluorescence In Situ Hybridization (FISH) Using DNA Probes.

Preferred specimen type is tissue block (formalin-fixed, paraffin-embedded).

Brian biopsy, BNP, CEA, MGMT (O-6-methylguanine-DNA methyltransferase) Methylation.
3-7 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login